RaySearch Laboratories AB (STU:27R) E10: €0.27 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:27R RaySearch Laboratories AB STU:27R
90 GF Score
Price €17.59
GF Value €17.06
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB E10?

RaySearch Laboratories AB STU:27R +2.63% 90 E10 is €0.27 as of Jun. 2026. GuruFocus rates STU:27R with a GF Score™ of 90/100 and a GF Value™ of €17.06 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

RaySearch Laboratories AB's adjusted earnings per share data for the three months ended in Jun. 2026 was €0.052. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.27 for the trailing ten years ended in Jun. 2026.

During the past 12 months, RaySearch Laboratories AB's average E10 Growth Rate was 10.50% per year. During the past 3 years, the average E10 Growth Rate was 18.10% per year. During the past 5 years, the average E10 Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of RaySearch Laboratories AB was 18.10% per year. The lowest was -3.40% per year. And the median was 4.85% per year.

As of today (2026-08-17), RaySearch Laboratories AB's current stock price is €17.59. RaySearch Laboratories AB's E10 for the quarter that ended in Jun. 2026 was €0.27. RaySearch Laboratories AB's Shiller PE Ratio of today is 65.15.

During the past 13 years, the highest Shiller PE Ratio of RaySearch Laboratories AB was 161.30. The lowest was 26.56. And the median was 58.84.


RaySearch Laboratories AB  (STU:27R) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

RaySearch Laboratories AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=17.59/0.27
=65.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of RaySearch Laboratories AB was 161.30. The lowest was 26.56. And the median was 58.84.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


RaySearch Laboratories AB E10 Related Terms


RaySearch Laboratories AB E10 Historical Data

* Premium members only.

The historical data trend for RaySearch Laboratories AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RaySearch Laboratories AB E10 Chart

RaySearch Laboratories AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.15 0.19 0.21 0.26

RaySearch Laboratories AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.25 0.26 0.27 0.27

STU:27R vs VEEV, BTSG, HQY: E10 Comparison

For the Health Information Services subindustry, RaySearch Laboratories AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB Shiller PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Shiller PE Ratio falls into.


STU:27R
90GF Score
RaySearch Laboratories AB STU:27R
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RaySearch Laboratories AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, RaySearch Laboratories AB's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.052/134.6100*134.6100
=0.052

Current CPI (Jun. 2026) = 134.6100.

RaySearch Laboratories AB Quarterly Data

per share eps CPI Adj_EPS
201609 0.088 101.138 0.117
201612 0.229 102.022 0.302
201703 0.081 102.022 0.107
201706 0.061 102.752 0.080
201709 -0.003 103.279 -0.004
201712 0.212 103.793 0.275
201803 0.033 103.962 0.043
201806 0.058 104.875 0.074
201809 0.037 105.679 0.047
201812 0.092 105.912 0.117
201903 0.048 105.886 0.061
201906 0.060 106.742 0.076
201909 -0.021 107.214 -0.026
201912 0.052 107.766 0.065
202003 0.108 106.563 0.136
202006 -0.026 107.498 -0.033
202009 -0.073 107.635 -0.091
202012 -0.040 108.296 -0.050
202103 0.021 108.360 0.026
202106 -0.047 108.928 -0.058
202109 -0.063 110.338 -0.077
202112 -0.046 112.486 -0.055
202203 0.053 114.825 0.062
202206 -0.055 118.384 -0.063
202209 0.027 122.296 0.030
202212 0.037 126.365 0.039
202303 0.045 127.042 0.048
202306 0.027 129.407 0.028
202309 0.053 130.224 0.055
202312 0.082 131.912 0.084
202403 0.095 132.205 0.097
202406 0.159 132.716 0.161
202409 0.116 132.304 0.118
202412 0.152 132.987 0.154
202503 0.152 132.825 0.154
202506 0.082 133.699 0.083
202509 0.190 133.480 0.192
202512 0.184 133.390 0.186
202603 0.144 133.560 0.145
202606 0.052 134.610 0.052

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.27 mean?
RaySearch Laboratories AB (STU:27R) has a E10 of €0.27 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on RaySearch Laboratories AB and its competitors.
Is RaySearch Laboratories AB's E10 too high?
RaySearch Laboratories AB's current E10 is €0.27. Overall, RaySearch Laboratories AB has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's E10 compare to VEEV and BTSG?
RaySearch Laboratories AB's E10 of €0.27 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Healthcare Providers & Services company?
A good E10 depends on the Healthcare Providers & Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on RaySearch Laboratories AB and its competitors. RaySearch Laboratories AB's current E10 is €0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (STU:27R) is currently considered Fairly Valued. The stock's GF Value™ is €17.06, compared to a current price of €17.59 — trading 3.1% above its estimated fair value. The current E10 is €0.27. RaySearch Laboratories AB's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For RaySearch Laboratories AB (STU:27R), the current E10 is €0.27 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RaySearch Laboratories AB (STU:27R) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued. The current stock price of €17.59 is trading 3.1% above its estimated GF Value™ of €17.06. GuruFocus considers RaySearch Laboratories AB to be Fairly Valued.

Key valuation signals for STU:27R:

  • E10: €0.27
  • GF Value™: €17.06 vs. price of €17.59 (3.1% above fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the STU:27R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
90GF Score

Get the complete analysis for STU:27R

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.59
Price
€17.06
GF Value